Effect of Ketogenic Diet on Obesity and Other Metabolic Disorders: Narrative Review
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Obesity is defined as an abnormal or excessive accumulation of fat that increases the burden of different chronic diseases in the population. It has reached epidemic proportions and is a major risk factor for a variety of diseases, including hypertension, cardiovascular disease, type 2 diabetes, dyslipidaemia, atherosclerosis, and some malignancies. Weight gain is a result of excessive energy intake compared to energy expenditure (energy loss from metabolism and physical exercise). A ketogenic diet has a more useful effect on obesity than other diets. A ketogenic diet is a low-carbohydrate, high-fat, moderate-protein diet that induces the production of ketone bodies by mimicking the breakdown of a fasting state. The mechanism behind the ketogenic diet is still unknown, although it obviously helps people with obesity lose weight. Several pathways for the ketogenic diet effect on weight loss have been hypothesized by researchers, including reduced appetite due to effects on appetite control hormones and a possible direct appetite suppressant action of ketone bodies; reduced lipogenesis and increased lipolysis; greater metabolic efficiency; and increased metabolic costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Regarding appetite and satiety, studies reported reductions in appetite during KD as well as no measurable effect in other interventions, resulting in inconsistent findings [51].”
From Dietary and Behavioral Strategies for Weight Loss and Weight Loss Maintenance: A Narrative Review (2025) · cites this paper as [51]
In the citing paper
“Data on the effect of the ketogenic diet on hunger and satiety remain inconsistent, so potential benefits in this area should be interpreted with caution [51].”
From Dietary and Behavioral Strategies for Weight Loss and Weight Loss Maintenance: A Narrative Review (2025) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070 · cited 1×
“7 Obesity is a main public health concern that increases the risk of developing comorbidities such as cardiovascular disease, diabetes, cancer, and musculoskeletal disorders, as well as respiratory issues, impaired cognitive functions, CVD, and an increased risk of premature death.”
BackgroundHealth effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
Mechanisms, Pathophysiology, and Management of Obesity
Heymsfield, S. B., & Wadden, T. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1514009 · Cited by 1,867 · cited 2×
“10 The CNS perceives information about adipose tissue, liver, stomach, muscle, and bone metabolic demands.”
BackgroundMulti-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Puchalska, P., & Crawford, P. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.022 · Cited by 1,610 · cited 2×
“33 Ketolysis is required to obtain energy from ketone substances.”
BackgroundPPARs and the complex journey to obesity
Evans, R. M., Barish, G. D., & Wang, Y.-X. (2004) · Nature Medicine · doi:10.1038/nm1025 · Cited by 1,602 · cited 1×
“19 As immune stimulators, these macrophages increase the activity of the mitogen-activated protein kinase family, which includes the C-Jun N-terminal kinase, inhibitor of NF-KB kinase b, and PI3K.”
BackgroundCahill, G. F. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111258 · Cited by 1,319 · cited 4×
“32 Ketone bodies are the outcome of a physiological state in which glucose reserves are insufficient to produce oxaloacetate for fat oxidation during the Krebs cycle.”
BackgroundInfluentialA Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity
Samaha, F. F., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, T., Williams, M., Gracely, E. J., & Stern, L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022637 · Cited by 1,267 · cited 1×
“41 Ketosis has a direct or indirect effect on the secretion of appetite related hormones, as they seem to exert an action on both orexigen and anorexigen signals, mainly BHB. 42 While working in the CNS to control eating behaviour through elevated gamma-amino butyric acid (GABA) and AMP-activated…”
BackgroundThe Definition and Prevalence of Obesity and Metabolic Syndrome
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_1 · Cited by 1,180
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151 · cited 1×
“60,61 The KD may also protect against NAFLD via a variety of mechanisms.”
BackgroundBifidobacteria and Their Role as Members of the Human Gut Microbiota
O'Callaghan, A., & van Sinderen, D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00925 · Cited by 1,080
Overweight and obesity: prevalence, consequences, and causes of a growing public health problem
Williams, E. P., Mesidor, M., Winters, K., Dubbert, P. M., & Wyatt, S. B. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0169-4 · Cited by 922 · cited 1×
“8,9”
Bueno, N. B., de Melo, I. S. V., de Oliveira, S. L., & da Rocha Ataide, T. (2013) · British Journal of Nutrition · doi:10.1017/s0007114513000548 · Cited by 778
Kossoff, E. H., Zupec‐Kania, B. A., Auvin, S., Ballaban‐Gil, K. R., Christina Bergqvist, A. G., Blackford, R., Buchhalter, J. R., Caraballo, R. H., Cross, J. H., Dahlin, M. G., et al. (2018) · Epilepsia Open · doi:10.1002/epi4.12225 · Cited by 768 · cited 1×
“27 The MCT KD was created in 1971.”
BackgroundAn Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases
Elagizi, A., Kachur, S., Lavie, C. J., Carbone, S., Pandey, A., Ortega, F. B., & Milani, R. V. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.07.003 · Cited by 698
Overweight and Obesity: Prevalence, Consequences, and Causes of a Growing Public Health Problem
Wyatt, S. B., Winters, K. P., & Dubbert, P. M. (2006) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200604000-00002 · Cited by 694
The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
Maalouf, M., Rho, J. M., & Mattson, M. P. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.09.002 · Cited by 574 · cited 1×
“53,54 In many studies, the KD has shown hopeful results in a variety of metabolic disorders such as T2DM, NAFLD, PCOS and CVD. 56 KDs have positive effects on several risk factors for cardiovascular disease.”
BackgroundKetogenic diet in the treatment of cancer – Where do we stand?
Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.026 · Cited by 464
β-Cell Mass and Turnover in Humans
Saisho, Y., Butler, A. E., Manesso, E., Elashoff, D., Rizza, R. A., & Butler, P. C. (2013) · Diabetes Care · doi:10.2337/dc12-0421 · Cited by 402
Do ketogenic diets really suppress appetite? A systematic review and meta‐analysis
Gibson, A. A., Seimon, R. V., Lee, C. M. Y., Ayre, J., Franklin, J., Markovic, T. P., Caterson, I. D., & Sainsbury, A. (2015) · Obesity Reviews · doi:10.1111/obr.12230 · Cited by 366
Gut microbiota: a new path to treat obesity
on behalf of the Obesity Programs of nutrition, E., Muscogiuri, G., Cantone, E., Cassarano, S., Tuccinardi, D., Barrea, L., Savastano, S., & Colao, A. (2019) · International Journal of Obesity Supplements · doi:10.1038/s41367-019-0011-7 · Cited by 354
Ketogenic Diet for Obesity: Friend or Foe?
Paoli, A. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110202092 · Cited by 352 · cited 2×
“…low glycaemic index therapy, which has a more lenient regimen with low-carbohydrate composition to prevent glycaemic increases (glycaemic indices 50), is an effective antiepileptic intervention in children with intractable epilepsy because it is based on the theory that the protective effect of…”
BackgroundObesity phenotypes and their paradoxical association with cardiovascular diseases
Vecchié, A., Dallegri, F., Carbone, F., Bonaventura, A., Liberale, L., Portincasa, P., Frühbeck, G., & Montecucco, F. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.10.020 · Cited by 329 · cited 1×
“17,18 The excessive accumulation of triacylglycerol in obesity leads to the release of excessive fatty acids from increased lipolysis, which is driven by obesity, raised sympathetic state.”
BackgroundThe Neuropharmacology of the Ketogenic Diet
Hartman, A. L., Gasior, M., Vining, E. P. G., & Rogawski, M. A. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.02.008 · Cited by 325 · cited 1×
“31 When the body’s supply of dietary CHO is depleted or nonexistent, such as during KD or fasting, the CNS turns to ketone bodies for energy (KBs).”
BackgroundEffects of a Ketogenic Diet in Overweight Women with Polycystic Ovary Syndrome
Paoli, A., Mancin, L., Giacona, M. C., Bianco, A., & Caprio, M. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02277-0 · Cited by 281
Angiotensin II is associated with activation of NF-κB-mediated genes and downregulation of PPARs
Tham, D. M., Martin-McNulty, B., Wang, Y.-X., Wilson, D. W., Vergona, R., Sullivan, M. E., Dole, W., & Rutledge, J. C. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00062.2002 · Cited by 277
Ketosis and appetite-mediating nutrients and hormones after weight loss
Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.90 · Cited by 260 · cited 1×
“…the following: (1) Reduced appetite due to increasing concentrations of “satiety” hormones, such as glucagon-like peptide-1, cholecystokinin, and 40 and a possible direct suppression of appetite by KBs, such as β-HB, which act both in energy/ satiety signalling and in mediating the central…”
BackgroundKetosis, ketogenic diet and food intake control: a complex relationship
Paoli, A., Bosco, G., Camporesi, E. M., & Mangar, D. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.00027 · Cited by 259 · cited 2×
“34 (2) Improved insulin resistance reduces lipogenesis, while enhanced expression of lipolytic enzymes such as adipose triglyceride lipase, hormone-sensitive lipase, and lipoprotein lipase increases lipolysis.”
BackgroundGoday, A., Bellido, D., Sajoux, I., Crujeiras, A. B., Burguera, B., García-Luna, P. P., Oleaga, A., Moreno, B., & Casanueva, F. F. (2016) · Nutrition & Diabetes · doi:10.1038/nutd.2016.36 · Cited by 258 · cited 1×
“24,25 Based on carbohydrate restrictions, there are four major types of KD: the classic (CKD), medium-chain triglyceride (MCT) KD, modified Atkins diet (MAD), and low glycaemic index treatment.”
BackgroundWatanabe, M., Tozzi, R., Risi, R., Tuccinardi, D., Mariani, S., Basciani, S., Spera, G., Lubrano, C., & Gnessi, L. (2020) · Obesity Reviews · doi:10.1111/obr.13024 · Cited by 215 · cited 1×
“62–64 The actual mechanism through which KD has a therapeutic effect in PCOS is unknown.”
BackgroundThe Ketogenic diet: from molecular mechanisms to clinical effects
(2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.10.003 · Cited by 213 · cited 1×
“23 Lennox and Stanley, two neurologists, examined the effects of fasting in the treatment of refractory epilepsy in both children and adults in the 1920s, and they recognized the advantages of a KD at that time.”
BackgroundMeex, R. C. R., Blaak, E. E., & van Loon, L. J. C. (2019) · Obesity Reviews · doi:10.1111/obr.12862 · Cited by 211 · cited 2×
“Higher metabolic efficiency in consuming fats that is indicated by the reduction in the resting respiratory quotient; 44,45 and (4) Enhanced energy consumption as a result of increased gluconeogenesis, a high-energy process that costs 400–600 Kcal/day, and the thermic action of protein, which has…”
BackgroundGut Microbiome and Obesity: A Plausible Explanation for Obesity
Sanmiguel, C., Gupta, A., & Mayer, E. A. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0152-0 · Cited by 204
Oussaada, S. M., van Galen, K. A., Cooiman, M. I., Kleinendorst, L., Hazebroek, E. J., van Haelst, M. M., ter Horst, K. W., & Serlie, M. J. (2019) · Metabolism · doi:10.1016/j.metabol.2018.12.012 · Cited by 180 · cited 1×
“12 As an environmental factor, the gut microbiome has a role in obesity.”
BackgroundLiu, H., Yang, Y., Wang, Y., Tang, H., Zhang, F., Zhang, Y., & Zhao, Y. (2018) · Epilepsia Open · doi:10.1002/epi4.12098 · Cited by 176 · cited 1×
“24,25 Based on carbohydrate restrictions, there are four major types of KD: the classic (CKD), medium-chain triglyceride (MCT) KD, modified Atkins diet (MAD), and low glycaemic index treatment.”
BackgroundGluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet
Veldhorst, M. A., Westerterp-Plantenga, M. S., & Westerterp, K. R. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27834 · Cited by 170
Sondhi, V., Agarwala, A., Pandey, R. M., Chakrabarty, B., Jauhari, P., Lodha, R., Toteja, G. S., Sharma, S., Paul, V. K., Kossoff, E., et al. (2020) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2020.2282 · Cited by 170
Liu, Y.-M., & Wang, H.-S. (2013) · Biomedical Journal · doi:10.4103/2319-4170.107154 · Cited by 166
Thermodynamics of weight loss diets
Fine, E. J., & Feinman, R. D. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-15 · Cited by 124 · cited 1×
“46,47 Gut bacteria may also play a role in weight loss, as consumption of KD increase the level of bacterially derived SCFA, which are known to decrease the appetite and energy intake. of Boosting the amount of bacteria that make SCFA.”
Timeline of changes in appetite during weight loss with a ketogenic diet
Nymo, S., Coutinho, S. R., Jørgensen, J. O. L., Rehfeld, J. F., Truby, H., Kulseng, B. E., & Martins, C. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.96 · Cited by 118 · cited 1×
“KD impacts adipose tissue and dyslipidemia by changing the subject’s metabolic pathways, reducing lipogenesis and increasing lipolysis 32,43 (3).”
BackgroundImpact of ketosis on appetite regulation—a review
Deemer, S. E., Plaisance, E. P., & Martins, C. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.02.010 · Cited by 106
Douris, N., Melman, T., Pecherer, J. M., Pissios, P., Flier, J. S., Cantley, L. C., Locasale, J. W., & Maratos-Flier, E. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.07.009 · Cited by 100 · cited 1×
“37 Several diets, including KD, low CHO, a nonketogenic diet and a Mediterranean diet, were used.”
MethodGower, B. A., & Goss, A. M. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.195065 · Cited by 98 · cited 1×
“51,52 Ketone bodies may have epigenetic cellular effects by inhibiting histone deacetylase (HDAC) enzymes, altering transcription differently and upregulating specific genes that code for bioenergetics enzymes (Figure 4).”
BackgroundTagliabue, A., Bertoli, S., Trentani, C., Borrelli, P., & Veggiotti, P. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.09.012 · Cited by 82 · cited 1×
“Higher metabolic efficiency in consuming fats that is indicated by the reduction in the resting respiratory quotient; 44,45 and (4) Enhanced energy consumption as a result of increased gluconeogenesis, a high-energy process that costs 400–600 Kcal/day, and the thermic action of protein, which has…”
BackgroundNonequilibrium thermodynamics and energy efficiency in weight loss diets
Feinman, R. D., & Fine, E. J. (2007) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-4-27 · Cited by 79
Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes
Jin, W., & Patti, M.-E. (2009) · Clinical Science · doi:10.1042/cs20080090 · Cited by 78 · cited 1×
“60,61 The KD may also protect against NAFLD via a variety of mechanisms.”
BackgroundMacfarlane, G. T., Gibson, G. R., Beatty, E., & Cummings, J. H. (1992) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.1992.tb00002.x · Cited by 76
Simeone, K. A., Matthews, S. A., Rho, J. M., & Simeone, T. A. (2016) · Epilepsia · doi:10.1111/epi.13444 · Cited by 73 · cited 1×
“51,52 Ketone bodies may have epigenetic cellular effects by inhibiting histone deacetylase (HDAC) enzymes, altering transcription differently and upregulating specific genes that code for bioenergetics enzymes (Figure 4).”
BackgroundCauses and solutions to “globesity”: The new fa(s)t alarming global epidemic
Mihaylova, L. V., Marchev, A. S., & Georgiev, M. I. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.08.071 · Cited by 68
The Critical Care Obesity Paradox and Implications for Nutrition Support
Patel, J. J., Rosenthal, M. D., Miller, K. R., Codner, P. A., Kiraly, L. N., & Martindale, R. G. (2016) · Current Gastroenterology Reports · doi:10.1007/s11894-016-0519-8 · Cited by 51
Cox, N., Gibas, S., Salisbury, M., Gomer, J., & Gibas, K. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.01.055 · Cited by 44 · cited 1×
“58 Proteins implicated in KD-induced pathways, such as Hydroxyacy1-CoA dehydrogenase 1 and Acyl-coenzyme an oxidase 1, are closely correlated with GLUT 4, an insulin-resistance pathway effector protein.”
BackgroundJagadish, S., Payne, E. T., Wong‐Kisiel, L. C., Nickels, K. C., Eckert, S., & Wirrell, E. C. (2018) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2018.12.012 · Cited by 41 · cited 1×
“30 Glucose is the body’s primary fuel, particularly for the central nervous system (CNS).”
BackgroundModulation of the gut microbiota-adipose tissue-muscle interactions by prebiotics
Rodriguez, J., & Delzenne, N. M. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0499 · Cited by 33
Farrés, J., Pujol, A., Coma, M., Ruiz, J. L., Naval, J., Mas, J. M., Molins, A. B., Fondevila, J., & Aloy, P. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-88 · Cited by 28
Höhn, S., Dozières‐Puyravel, B., & Auvin, S. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.03.018 · Cited by 28
Paoli, A., Cenci, L., Fancelli, M., Parmagnani, A., Fratter, A., Cucchi, A., & Bianco, A. (2010) · Nova Science Publishers (Nova Science Publishers, Inc.) · Cited by 26
Consenso nacional sobre dieta cetogénica
Armeno, M. L., Caraballo, R. H., Ferrari, M. V., Alberti, M. J., Ríos, V. G., Galicchio, S., Grandis, E. S. D., Mestre, G., Escobal, N., Matarrese, P., et al. (2014) · Revista de Neurología · doi:10.33588/rn.5905.2014277 · Cited by 24
Calcaterra, V., Verduci, E., Pascuzzi, M. C., Magenes, V. C., Fiore, G., Profio, E. D., Tenuta, E., Bosetti, A., Todisco, C. F., D’Auria, E., et al. (2021) · Nutrients · doi:10.3390/nu13082805 · Cited by 24
Ketogenesis and SIRT1 as a tool in managing obesity
Abduraman, M. A., Azizan, N. A., Teoh, S. H., & Tan, M. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.12.001 · Cited by 21 · cited 1×
“53,54 In many studies, the KD has shown hopeful results in a variety of metabolic disorders such as T2DM, NAFLD, PCOS and CVD. 56 KDs have positive effects on several risk factors for cardiovascular disease.”
BackgroundCastaldo, G., Palmieri, V., Galdo, G., Castaldo, L., Molettieri, P., Vitale, A., & Monaco, L. (2015) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.05.001 · Cited by 19 · cited 1×
“59 In diabetic mice, KD treatment reduced glucose transporter type 2 mRNA expression while increasing fibroblast growth factor 21 mRNA expression.”
BackgroundNot your parents’ ketogenic diet – Flexibility in 2020
Blackford, R. (2020) · Epilepsy Research · doi:10.1016/j.eplepsyres.2020.106307 · Cited by 18 · cited 1×
“26 The most conventional form of KD is CKD, which is often used in therapeutic settings.”
BackgroundImpact of obesity and diabetes on arthritis: An update
Pandey, R., Kumar, N., Paroha, S., Prasad, R., Yadav, M. K., Jain, S., & Yadav, H. (2013) · Health · doi:10.4236/health.2013.51019 · Cited by 17 · cited 2×
“16 Figure 2 illustrates common pathways by which the metabolic and physiological effects of excessive adiposity conduct to coexisting disorders and diseases in obesity.”
BackgroundMulti-Dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Crawford, P. A. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2018.11.034 · Cited by 6
Research works printed but not linked: 4
- Engin, 2017, Obes Lipotoxic, 3, 1
- 2020, Pathophysiology of Obesity-Induced Health Complications
- Qinghua, 2013, China Pharma, 2, 1
- O’Callaghan, 2016, Front Microbiol, 2, 925
Cited by
The Gut Microbiome in Human Obesity: A Comprehensive Review
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Biomedicines · doi:10.3390/biomedicines13092173 · Cited by 64
“…reduced lipogenesis, increased lipolysis, and enhanced fat oxidation, have shown short-to medium-term benefits in terms of weight loss and cardiometabolic health in obese patients, although careful monitoring and a gradual transition to a normal diet are essential for safety and adherence [84,85].”
Ahmad, Y., Seo, D. S., & Jang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137076 · Cited by 49
“Various studies have shown a individuals [19]. augmenting glycemic a KD for 56 index, total cholesterol, low-density lipoprotein cholesterol, triglycerides, and blood glucose levels, as well [15].”
BackgroundAkansel, M. G., Baş, M., Gençalp, C., Kahrıman, M., Şahin, E., Öztürk, H., Gür, G., & Gür, C. (2024) · Nutrients · doi:10.3390/nu16244374 · Cited by 29
Dina, C., Ţiţ, D. M., Radu, A.-F., Bungau, G., & Radu, A.-F. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47060440 · Cited by 32
“Independent of weight loss, this diet enhances insulin function and lipid profiles [126,127].”
Dietary and Behavioral Strategies for Weight Loss and Weight Loss Maintenance: A Narrative Review
Żurawski, T., & Bartosiewicz, A. (2025) · Nutrients · doi:10.3390/nu18010012 · Cited by 18
“Data on the effect of the ketogenic diet on hunger and satiety remain inconsistent, so potential benefits in this area should be interpreted with caution [51].”
Metadata
- Authors
- Baylie, T., Ayelgn, T., Tiruneh, M., & Tesfa, K.
- Affiliations
- Debre Markos University (ET)
- University of Gondar (ET)
- Corresponding author
- Baylie, Temesgen
- Venue
- Diabetes, Metabolic Syndrome and Obesity
- Publisher
- Informa UK Limited
- Published
- 2024-03
- Volume
- Volume 17
- Pages
- 1391-1401
- ISSN
- 1178-7007 (ISSN-L)
- PMC
- PMC10962461
- OpenAlex
- W4393059930
- Cited by
- 27
- References
- 63
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 4
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diabetes Metabolic Syndrome and Obesity (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- ketogenic diet, obesity, weight loss, ketone bodies, appetite regulation, lipolysis, lipogenesis, metabolic efficiency, type 2 diabetes, cardiovascular disease, dyslipidemia, atherosclerosis, hypertension, metabolic disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.